Delivery Order SPE2DB22D1017-SPE2DB25FG4DF

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, with a ceiling value of $14,187.76 and a completion date of May 28, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The total ceiling value of the contract is $54,775.98, with a performance period extending until May 15, 2025. This contract is not designated as a set-aside, indicating open competition. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,508.20, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical supplies. The contract has an ultimate completion date of May 20, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is a part of the company's...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. The contract has a ceiling value of $8,981.43 and a period of performance through June 12, 2025. This delivery order contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a medical product, with an ultimate completion date of May 15, 2025 and a ceiling value of $3,910.45. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $11,238.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, which is a specialized medication. The contract has an ultimate completion date of March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 firm-fixed-price contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm-fixed-price delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,298.24, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,133.64 and a completion date of May 15, 2025. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a ceiling value of $9,420.09 and a completion date of June 10, 2025. The contract is a firm fixed price, non-set-aside vehicle, meaning it was open to full and open competition. AmerisourceBergen Drug Corp...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4DF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a ceiling value of $9,226.47 and an ultimate completion date of June 4, 2025. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract supports the federal government's medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/2/25, 9:51 AM